If you've been scrolling through social media lately, you may have come across GLP-1 patches being promoted as a cheaper, easier alternative to weight loss injections
Naturally regenerate your skin with Juveas microneedling service
Contrastingly, GLP1 antagonist sales in 2023 showcase a more diversified landscape, with therapeutics such as Ozempic, Trulicity, and Mounjaro driving 71 per cent of the sales. Looking ahead, the GLP1 agonist market is poised for robust growth, anticipating a 19.2 per cent compound annual growth rate (CAGR) from 2023 to 2029, reaching a substantial market size of $105 billion in 2029
Tester reviews: Our team tried many of the supplements on our list and shared firsthand feedback to help us decide which products to include
Microbial Overgrowth Sometimes, bacteria that belong in the large intestine migrate into the small intestine